Giovanni Giurdanella

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti et al. · Neuropharmacology · 2018 · 91 citations

Medicine, Neuroscience, Pharmacology +13

P2X7 receptor antagonism: Implications in diabetic retinopathy

Chiara Bianca Maria Platania, Giovanni Giurdanella, Luisa Di Paola et al. · Biochemical Pharmacology · 2017 · 82 citations

Medicine, Ophthalmology, Pharmacology +14

Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

Gabriella Lupo, Carla Motta, Giovanni Giurdanella et al. · Biochemical Pharmacology · 2013 · 76 citations

Life Sciences, Biochemistry, Ophthalmology +16

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway

Francesca Lazzara, Annamaria Fidilio, Chiara Bianca Maria Platania et al. · Biochemical Pharmacology · 2019 · 76 citations

Medicine, Cell Biology, Ophthalmology +16

Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway

Giovanni Giurdanella, Carmelina Daniela Anfuso, Melania Olivieri et al. · Biochemical Pharmacology · 2015 · 69 citations

Medicine, Ophthalmology, Pharmacology +16